Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun;8(12):773.
doi: 10.21037/atm.2020.02.153.

Immunotherapy in cervical cancer: the advent of precision medicine

Francesca De Felice  1 , Claudia Marchetti  2 , Anna Fagotti  2   3 , Giovanni Scambia  2   3
Affiliations
Editorial

Immunotherapy in cervical cancer: the advent of precision medicine

Francesca De Felice et al. Ann Transl Med. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.02.153). The authors have no conflicts of interest to declare.

Comment on

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. 10.3322/caac.21590 - DOI - PubMed
    1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Cervical Cancer. Version 1.2020. Available online: https://www.nccn.org
    1. Marchetti C, De Felice F, Di Pinto A, et al. Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer. Cancer Res Treat 2018;50:768-76. 10.4143/crt.2017.141 - DOI - PMC - PubMed
    1. Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009;27:4649-55. 10.1200/JCO.2009.21.8909 - DOI - PMC - PubMed
    1. Tewari KS, Sill MW, Long HJ, 3rd, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014;370:734-43. 10.1056/NEJMoa1309748 - DOI - PMC - PubMed